A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccine

Miki Wada; Senhong Lee; Paul Curnow; Ian Simpson; Adrian Mar

doi:10.1016/j.jdcr.2022.04.020

A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccine

JAAD Case Rep. 2022 Jun:24:74-77. doi: 10.1016/j.jdcr.2022.04.020. Epub 2022 May 2.

Authors

Miki Wada¹, Senhong Lee¹, Paul Curnow¹, Ian Simpson², Adrian Mar¹

Affiliations

¹ Department of Dermatology, Monash Health, Clayton, Victoria, Australia.
² Department of Pathology, Monash Health, Clayton, Victoria, Australia.

No abstract available

Keywords: AZ, AstraZeneca ChAdOx1 nCoV-19 Vaxzevria vaccine; COVID-19; ChAdOx1 COVID-19 vaccine; PRP, pityriasis rubra pilaris; adverse effect; cutaneous adverse effect; erythroderma; pityriasis rubra pilaris; vaccine.

Publication types

Case Reports